2024-11-16 04:43:34
Artificial Intelligence Is Propelling the Pharmaceutical Industry by Enabling Smart Drug Discovery Solutions
Health/ 2023-07-22
Artificial Intelligence Is Propelling th...

AI creates growth opportunities in novel therapeutics development by leveraging multi-sourced data,finds Frost & Sullivan

Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform
Corporate/ 2023-07-23
Ajinomoto and XL-protein Forge Strategic...

SAN DIEGO and FREISING,Germany,Dec. 18,2018--Ajinomoto Bio-Pharma Services,a fully owned subsidiary of Ajinomoto Co. Inc. (TSE: 2802),and XL...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release